1. Dekker, E, Chiu, H-M, Lansdorp-Vogelaar, I, et al. Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era. Gastroenterology 2020; 159: 1998–2003.
Google Scholar | Crossref | Medline2. Schreuders, EH, Ruco, A, Rabeneck, L, et al. Colorectal cancer screening: A global overview of existing programmes. Gut 2015; 64: 1637–1649.
Google Scholar | Crossref | Medline | ISI3. Cancer Australia . Review of the impact of COVID-19 on medical services and procedures in Australia utilising MBS data: Skin, breast and colorectal cancers, and telehealth services. Surry Hills, NSW, September 2020.
Google Scholar4. Meester, RGS, Zauber, AG, Doubeni, CA, et al. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clinical Gastroenterology and Hepatology 2016; 14: 1445–1451.e8.
Google Scholar | Crossref | Medline5. Rutter, CM, Kim, JJ, Meester, RGS, et al. Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: A modeling study. Cancer Epidemiology Biomarkers and Prevention 2018; 27: 158–164.
Google Scholar | Crossref | Medline6. Mizuno, R, Ganeko, R, Takeuchi, G, et al. The number of obstructive colorectal cancers in Japan has increased during the COVID-19 pandemic: A retrospective single-center cohort study. Annals of Medicine and Surgery 2020; 60: 675–679.
Google Scholar | Crossref | Medline7. Degeling, K, Baxter, N, Emery, J, et al. An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic. medRxiv 2020; 30: 20117630.
Google Scholar8. Maringe, C, Spicer, J, Morris, M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet Oncology 2020; 21: 1023–1034.
Google Scholar | Crossref | Medline9. de Jonge, L, Worthington, J, van Wifferen, F, et al. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. The Lancet Gastroenterology & Hepatology 2021; 6: 304–318.
Google Scholar | Crossref | Medline10. Young, GP, Woodman, RJ, Symonds, E. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold. BMJ Open Gastro 2020; 7: 517.
Google Scholar | Crossref11. Selby, K, Levine, EH, Doan, C, et al. Effect of Sex, Age and Positivity Threshold on Fecal Immunochemical Test Accuracy: a Systematic Review and Meta-Analysis. Gastroenterology 2019; 157: 1494–1505.
Google Scholar | Crossref | Medline12. Loeve, F, Boer, R, van Oortmarssen, GJ, et al. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Computers and Biomedical Research 1999; 32: 13–33.
Google Scholar | Crossref | Medline13. Greuter, MJE, Xu, XM, Lew, Jb, et al. Modeling the adenoma and serrated pathway to colorectal cancer (ASCCA). Risk Analysis 2014; 34: 889–910.
Google Scholar | Crossref | Medline14. Lew, Jb, St John, DJB, Xu, XM, et al. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. The Lancet Public Health 2017; 2: e331–e340.
Google Scholar | Crossref | Medline15. Lew, Jb, Greuter, MJE, Caruana, M, et al. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Medical Decision Making 2020; 40: 815–829.
Google Scholar | SAGE Journals | ISI16. Coldman, A, Pader, J, Gauvreau, C, et al. Simulating results from trials of sigmoidoscopy screening using the OncoSim microsimulation model. Journal of Cancer Policy 2018; 15: 52–58.
Google Scholar | Crossref17. World Bank Open Data . The World Bank, https://data.worldbank.org/ (accessed January 12, 2021).
Google Scholar18. National Institute for Public Health and the Environment (RIVM), Netherlands Comprehensive Cancer Organisation (IKNL). Monitor bevolkingsonderzoek darmkanker 2018. 2019.
Google Scholar19. Australian Institute of Health and Welfare . National Bowel Cancer Screening Program: monitoring report 2019. Cancer series no. 125. Cat. no. CAN 125. Canberra, 2019.
Google Scholar20. Statistics Canada. Cancer Screening , 2017, https://www150.statcan.gc.ca/n1/pub/82-625-x/2018001/article/54977-eng.htm (accessed March 1, 2021).
Google Scholar21. World Health Organization: International Agency for Research on Cancer . GLOBOCAN 2020., https://gco.iarc.fr/ (accessed January 7, 2021).
Google Scholar22. Walker, MJ, Meggetto, O, Gao, J, et al. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Preventive Medicine 2021; 151: 106586.
Google Scholar | Crossref | Medline23. Kortlever, TL, Jonge, Ld, Wisse, PHA, et al. The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic. Preventive Medicine 2021; 151: 106643.
Google Scholar | Crossref | Medline24. de Klerk, CM, Wieten, E, Lansdorp-Vogelaar, I, et al. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme. The Lancet Gastroenterology and Hepatology 2019; 4: 111–118.
Google Scholar | Crossref | Medline25. Toes-Zoutendijk, E, van Leerdam, ME, Dekker, E, et al. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels. Gastroenterology 2017; 152: 767–775.e2.
Google Scholar | Crossref | Medline26. de Neree tot Babberich, MPM, Ledeboer, M, van Leerdam, ME, et al. Dutch Gastrointestinal Endoscopy Audit: automated extraction of colonoscopy data for quality assessment and improvement. Gastrointestinal Endoscopy 2020; 92: 154–162.e1.
Google Scholar | Crossref | Medline27. Click, B, Pinsky, PF, Hickey, T, et al. Association of colonoscopy adenoma findings with long-term colorectal cancer incidence. JAMA - Journal of the American Medical Association 2018; 319: 2021–2031.
Google Scholar | Crossref | Medline28. Greuter, MJE, de Klerk, CM, Meijer, GA, et al. Screening for colorectal cancer with fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy: A cost-effectiveness analysis. Annals of Internal Medicine 2017; 167: 544–554.
Google Scholar | Crossref | Medline29. Corley, DA, Jensen, CD, Quinn, VP, et al. Association Between Time to Colonoscopy After a Positive Fecal Test and Risk of Colorectal Cancer Stage at Diagnosis HHS Public Access. JAMA 2017; 317: 1631–1641.
Google Scholar | Crossref | Medline30. Lee, YC, Fann, JCY, Chiang, TH, et al. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests. Clinical Gastroenterology and Hepatology 2019; 17: 1332–1340. e3.
Google Scholar | Crossref | Medline31. White, A, Ironmonger, L, Steele, RJC, et al. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer 2018; 18: 906.
Google Scholar | Crossref | Medline32. Arana-Arri, E, Idigoras, I, Uranga, B, et al. Population-based colorectal cancer screening programmes using a faecal immunochemical test: Should faecal haemoglobin cut-offs differ by age and sex? BMC Cancer Epub ahead of print August 29, 2017; 17. DOI: 10.1186/s12885-017-3555-3
Google Scholar | Crossref | Medline33. Blom, J, Löwbeer, C, Elfström, KM, et al. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate. Journal of Medical Screening 2018; 26: 92–97.
Google Scholar | SAGE Journals34. van der Meulen, MP, Kapidzic, A, van Leerdam, ME, et al. Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis. Cancer Epidemiol Biomarkers Prev 2017; 26: 1328–1336.
Google Scholar | Crossref | Medline35. Loveday, C, Sud, A, Jones, ME, et al. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study. Gut 2020; 0: 1–8.
Google Scholar36. A Colonoscopy Wait-time and Performance Guarantee - Early Detection - Bowel Cancer Australia, https://www.bowelcanceraustralia.org/a-colonoscopy-wait-time-and-performance-guarantee (accessed February 22, 2021).
Google Scholar